Published in Arch Bronconeumol on November 01, 2008
Functional Respiratory Imaging in Bronchiectasis (FRIBE) | NCT03818646
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations. Int J Chron Obstruct Pulmon Dis (2011) 1.04
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2014) 1.02
Surgical treatment of bronchiectasis: a retrospective observational study of 138 patients. J Thorac Dis (2013) 0.93
The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res (2016) 0.80
Eradication of Burkholderia cepacia Using Inhaled Aztreonam Lysine in Two Patients with Bronchiectasis. Case Rep Pulmonol (2014) 0.79
Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study. BMC Infect Dis (2016) 0.78
Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013). PLoS One (2016) 0.77
Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. Open Respir Med J (2015) 0.77
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation. Int J Chron Obstruct Pulmon Dis (2016) 0.76
Inhaled Antibiotics for Gram-Negative Respiratory Infections. Clin Microbiol Rev (2016) 0.76
Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations. PLoS One (2017) 0.75
[A united airway: bronchiectasis is also associated with chronic rhinosinusitis and nasal polyps]. Arch Bronconeumol (2009) 0.75
Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin. Eurasian J Med (2017) 0.75
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study. Respir Res (2017) 0.75
Evaluation of obstructive sleep apnea in non-cystic fibrosis bronchiectasis: A cross-sectional study. PLoS One (2017) 0.75
Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations. BMC Infect Dis (2017) 0.75
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis (2008) 6.21
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care (2009) 3.48
Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother (2002) 3.23
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med (2008) 3.23
Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol (2008) 2.96
Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol (2004) 2.90
Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother (2008) 2.88
[Thromboembolic events in patients after a negative computed tomography pulmonary angiogram: A retrospective study of 165 patients]. Arch Bronconeumol (2006) 2.64
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents (2007) 2.61
Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol (2006) 2.49
Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother (2011) 2.42
Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. Hepatology (2007) 2.14
[Prevalence of anemia and its correlation with clinical parameters in patients from a multidisciplinary heart failure unit]. Med Clin (Barc) (2004) 2.02
Unfinished stories on viral quasispecies and Darwinian views of evolution. J Mol Biol (2010) 2.00
Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob Agents Chemother (2006) 1.79
Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-alpha, and IncFI groups. Antimicrob Agents Chemother (2006) 1.79
Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int J Antimicrob Agents (2009) 1.74
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo. Virus Res (2008) 1.70
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis (2007) 1.70
Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. Antimicrob Agents Chemother (2009) 1.70
High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol (2008) 1.64
Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6')-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob Agents Chemother (2006) 1.64
Serum phospholipid fatty acid profile and dietary intake in an adult Mediterranean population with cystic fibrosis. Br J Nutr (2006) 1.55
TACI mutation in Good's Syndrome: in search of a genetic basis. Clin Immunol (2012) 1.54
Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanisms. Diagn Microbiol Infect Dis (2006) 1.54
Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother (2008) 1.53
[Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)]. Enferm Infecc Microbiol Clin (2003) 1.53
[Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005)]. Enferm Infecc Microbiol Clin (2008) 1.52
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother (2006) 1.52
Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother (2005) 1.50
Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One (2012) 1.48
Markers for the validation of reported dietary intake in adults with cystic fibrosis. J Am Diet Assoc (2009) 1.47
[Prognostic significance of hemoglobin levels in patients with heart failure]. Rev Esp Cardiol (2005) 1.45
Paediatric patients with a tracheostomy: a multicentre epidemiological study. Eur Respir J (2012) 1.44
[Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)]. Enferm Infecc Microbiol Clin (2008) 1.43
Bronchial reactivity indices are determinants of health-related quality of life in patients with stable asthma. Thorax (2010) 1.42
[Prognostic significance of diabetes in a heart failure population: one year mortality and heart failure related hospital admission]. Med Clin (Barc) (2005) 1.42
High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients. J Antimicrob Chemother (2002) 1.41
Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J (2012) 1.38
Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol (2011) 1.35
Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother (2010) 1.33
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J Antimicrob Chemother (2011) 1.29
Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004. J Infect (2007) 1.27
High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol (2004) 1.27
Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog (2010) 1.26
Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J Clin Microbiol (2004) 1.25
Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.25
Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob Agents Chemother (2005) 1.24
Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue? J Clin Microbiol (2011) 1.22
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J (2013) 1.19
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother (2010) 1.19
Antibiotic resistance integrons and extended-spectrum {beta}-lactamases among Enterobacteriaceae isolates recovered from chickens and swine in Portugal. J Antimicrob Chemother (2008) 1.18
IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients. PLoS One (2010) 1.17
Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations. J Clin Microbiol (2004) 1.16
CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents Chemother (2005) 1.16
Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain. J Antimicrob Chemother (2013) 1.14
Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl Environ Microbiol (2010) 1.14
[Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study]. Arch Bronconeumol (2008) 1.13
Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J Virol (2006) 1.12
HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol (2006) 1.10
Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J Clin Microbiol (2005) 1.10
[Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis]. Enferm Infecc Microbiol Clin (2009) 1.09
MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros (2011) 1.08
Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. Int J Antimicrob Agents (2013) 1.08
Global spread of the hyl(Efm) colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster. Antimicrob Agents Chemother (2010) 1.07
Fitness landscape of human immunodeficiency virus type 1 protease quasispecies. J Virol (2006) 1.06
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient. Rev Esp Quimioter (2013) 1.06
Learning from mistakes: Taq polymerase contaminated with beta-lactamase sequences results in false emergence of Streptococcus pneumoniae containing TEM. J Antimicrob Chemother (2007) 1.06
Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures. J Antimicrob Chemother (2006) 1.05
Preservation of integron types among Enterobacteriaceae producing extended-spectrum beta-lactamases in a Spanish hospital over a 15-year period (1988 to 2003). Antimicrob Agents Chemother (2007) 1.05
Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients. PLoS One (2012) 1.05
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario? Antimicrob Agents Chemother (2011) 1.04
Common variable immunodeficiency: association between memory B cells and lung diseases. Chest (2007) 1.04
High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother (2008) 1.04
Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance. J Antimicrob Chemother (2003) 1.03
Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains. J Antimicrob Chemother (2005) 1.02
Commensal Enterobacteriaceae as reservoirs of extended-spectrum beta-lactamases, integrons, and sul genes in Portugal. Front Microbiol (2013) 1.02
Melioidosis in traveler from Africa to Spain. Emerg Infect Dis (2013) 1.01
Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches. AIDS (2004) 1.01
High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother (2007) 1.00
Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother (2009) 0.99
[High-risk clonal complexes CC2 and CC9 are widely distributed among Enterococcus faecalis hospital isolates recovered in Spain]. Enferm Infecc Microbiol Clin (2007) 0.99
Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients. J Clin Microbiol (2012) 0.99
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization. Prev Med (2012) 0.98
Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization. J Microbiol Methods (2010) 0.98
Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance. Antimicrob Agents Chemother (2008) 0.97
Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium. Diagn Microbiol Infect Dis (2010) 0.97
Epistasis among deleterious mutations in the HIV-1 protease. J Mol Biol (2009) 0.96
Assessing the use of the "opening angle method" to enforce residual stresses in patient-specific arteries. Ann Biomed Eng (2007) 0.95
Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient. J Clin Microbiol (2012) 0.95
Normal mutation rate variants arise in a Mutator (Mut S) Escherichia coli population. PLoS One (2013) 0.94
The obesity paradox in heart failure: is etiology a key factor? Int J Cardiol (2011) 0.94